These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37592616)

  • 1. Lessons Learned from the MAUDE Database on Transvaginal Synthetic Mesh and Sling Reports.
    Abraham A; Tzartzeva K; Christie A; Zimmern P
    Urol Pract; 2017 Mar; 4(2):111-117. PubMed ID: 37592616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manufacturer and User Facility Device Experience Reporting of Events Related to Transvaginal Mesh: Understanding the Data.
    Dallas K; Souders CP; Caron A; Clark K; Obi N; McClelland L; Chughtai B; Eilber KS; Anger JT
    Female Pelvic Med Reconstr Surg; 2022 May; 28(5):332-335. PubMed ID: 35421039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events Associated With Synthetic Male Slings: An Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database.
    Zhao H; Souders CP; Kuhlmann PK; Dallas K; Eilber K; Anger JT
    Int Neurourol J; 2021 Jun; 25(2):172-176. PubMed ID: 33957719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh.
    Sandberg JM; Gray I; Pearlman A; Terlecki RP
    Investig Clin Urol; 2018 Mar; 59(2):126-132. PubMed ID: 29520389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of Mesh Utilization for Stress Urinary Incontinence Before and After the 2011 Food and Drug Administration Notification Between FPMRS-Certified and Non-FPMRS-Certified Physicians: A Statewide All-Payer Database Analysis.
    Siegal AR; Huang Z; Gross MD; Mehraban-Far S; Weissbart SJ; Kim JM
    Urology; 2021 Apr; 150():151-157. PubMed ID: 32663554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Placement and Removal or Revision of Transvaginal Mesh for Pelvic Organ Prolapse and Stress Urinary Incontinence in the Ambulatory Setting before and after the 2011 Food and Drug Administration Notification.
    Polland A; Meckel K; Trop CS
    Urol Pract; 2015 Jul; 2(4):160-164. PubMed ID: 37559260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesh complications in female pelvic floor reconstructive surgery and their management: A systematic review.
    Shah HN; Badlani GH
    Indian J Urol; 2012 Apr; 28(2):129-53. PubMed ID: 22919127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Analysis of the FDA MAUDE Database and the Search for Cobalt Toxicity in Class 3 Johnson & Johnson/DePuy Metal-on-Metal Hip Implants.
    Kavanagh KT; Kraman SS; Kavanagh SP
    J Patient Saf; 2018 Dec; 14(4):e89-e96. PubMed ID: 30308590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications Reported to the Food and Drug Administration: A Cross-sectional Comparison of Urogynecologic Meshes.
    Artsen AM; Sassani JC; Moalli PA; Bradley MS
    Female Pelvic Med Reconstr Surg; 2022 Jul; 28(7):452-460. PubMed ID: 35536679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal.
    McCoy O; Vaughan T; Nickles SW; Ashley M; MacLachlan LS; Ginsberg D; Rovner E
    J Urol; 2016 Aug; 196(2):484-9. PubMed ID: 26997314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications and Complications Associated with the Removal of 506 Pieces of Vaginal Mesh Used in Pelvic Floor Reconstruction: A Multicenter Study.
    Miklos JR; Chinthakanan O; Moore RD; Karp DR; Nogueiras GM; Davila GW
    Surg Technol Int; 2016 Oct; 29():185-189. PubMed ID: 27780347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update.
    Koo K; Gormley EA
    Neurourol Urodyn; 2017 Feb; 36(2):329-332. PubMed ID: 26575470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between the Amount of Vaginal Mesh Used With Mesh Erosions and Repeated Surgery After Repairing Pelvic Organ Prolapse and Stress Urinary Incontinence.
    Chughtai B; Barber MD; Mao J; Forde JC; Normand ST; Sedrakyan A
    JAMA Surg; 2017 Mar; 152(3):257-263. PubMed ID: 27902825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Concomitant Stress Incontinence Surgery at Time of Pelvic Organ Prolapse Surgery Since Release of the 2011 Notification on Serious Complications Associated with Transvaginal Mesh.
    Drain A; Khan A; Ohmann EL; Brucker BM; Smilen S; Rosenblum N; Nitti VW
    J Urol; 2017 Apr; 197(4):1092-1098. PubMed ID: 27866958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the 2011 FDA transvaginal mesh safety update on AUGS members' use of synthetic mesh and biologic grafts in pelvic reconstructive surgery.
    Clemons JL; Weinstein M; Guess MK; Alperin M; Moalli P; Gregory WT; Lukacz ES; Sung VW; Chen BH; Bradley CS;
    Female Pelvic Med Reconstr Surg; 2013; 19(4):191-8. PubMed ID: 23797515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vaginal mesh procedures in pelvic organ prolapse surgery in view of complication risk.
    Ellington DR; Richter HE
    Obstet Gynecol Int; 2013; 2013():356960. PubMed ID: 24069035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends of Urogynecologic Mesh Reports to the U.S. Food and Drug Administration.
    Sassani JC; Artsen AM; Moalli PA; Bradley MS
    Obstet Gynecol; 2020 May; 135(5):1084-1090. PubMed ID: 32282600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporter's occupation and source of adverse device event reports contained in the FDA's MAUDE database.
    Kavanagh KT; Brown RE; Kraman SS; Calderon LE; Kavanagh SP
    Patient Relat Outcome Meas; 2019; 10():205-208. PubMed ID: 31308772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the 2011 US Food and Drug Administration transvaginal mesh communication on utilization of synthetic mid-urethral sling procedures.
    Berger AA; Tan-Kim J; Menefee SA
    Int Urogynecol J; 2021 Aug; 32(8):2227-2231. PubMed ID: 33206220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic mesh complications in women before and after the 2011 FDA public health notification.
    Rice NT; Hu Y; Slaughter JC; Ward RM
    Female Pelvic Med Reconstr Surg; 2013; 19(6):333-8. PubMed ID: 24165446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.